Compare BMHL & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMHL | SEER |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | Hong Kong | United States |
| Employees | 9 | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 97.3M |
| IPO Year | N/A | 2020 |
| Metric | BMHL | SEER |
|---|---|---|
| Price | $3.94 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.4K | ★ 513.9K |
| Earning Date | 06-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $66.66 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $2.72 | $1.65 |
| 52 Week High | $4.48 | $2.41 |
| Indicator | BMHL | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 43.18 |
| Support Level | $3.25 | $1.71 |
| Resistance Level | $4.20 | $1.84 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 92.31 | 0.00 |
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.